You will receive alerts when there are new announcements on Recce Pharmaceuticals Ltd
Only registered members can use this feature.
or
Recce Pharmaceuticals Ltd (ASX:RCE) is developing a new class of synthetic anti-infectives designed to address the urgent global health threat of antibiotic-resistant superbugs.
Copyright © Proactive Group Holdings Inc, 2026
All Rights Reserved - Proactive Australia PTY LTD ACN:132787654 ABN:19132787654.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.